CONNECTA Therapeutics
- Biotech or pharma, therapeutic R&D
CONNECTA Therapeutics is a clinical stage biotech company based in Barcelona developing new treatments for CNS diseases with a strong commitment to orphan and paediatric indications. CONNECTA’s leading program is focused on the clinical development of CTH120, now in Phase II, a first-in-class neuroplasticity modulator, orally bioavailable, with a clinically validated safety profile and broad therapeutic applications
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}